Search results for "Heart failure"
SGLT-2 inhibitors more effective than sulfonylureas, DPP-4 inhibitors as second-line therapy
Patients with type 2 diabetes who added a sodium-glucose cotransporter-2 (SGLT-2) inhibitor to metformin had greater reductions in HbA1c level and body mass at one year than those who added a sulfonylurea or dipeptidyl peptidase-4 (DPP-4) inhibitor, a U.K. study found.
https://immattersacp.org/weekly/archives/2024/05/14/4.htm
14 May 2024
Salt tablets no salve for hyponatremia
At Kidney Week in fall 2023, an endocrinologist covered the latest in outpatient diagnosis and treatment of syndrome of inappropriate antidiuresis (SIAD).
https://immattersacp.org/archives/2024/02/salt-tablets-no-salve-for-hyponatremia.htm
1 Feb 2024
Diagnose, address cognitive impairment in heart failure patients, society says
A new scientific statement from the Heart Failure Society of America advises clinicians to be alert to clues such as difficulty with money or running out of medicine, among other recommendations.
https://immattersacp.org/weekly/archives/2024/03/19/4.htm
19 Mar 2024
Take a team approach to coronary disease
A major update to a cardiology guideline puts team-based, patient-centered care at the forefront of management and highlights the role of healthy diet and exercise habits in reducing cardiovascular risk.
https://immattersacp.org/archives/2024/02/take-a-team-approach-to-coronary-disease.htm
1 Feb 2024
Adherence to sleep apnea treatment reduces health care use, costs in heart failure
Positive airway pressure-adherent patients with heart failure with preserved ejection fraction and obstructive sleep apnea had fewer health care visits, including ED and hospital visits, than nonadherent patients, according to a new industry-funded study.
https://immattersacp.org/weekly/archives/2023/07/18/2.htm
18 Jul 2023
Quadruple therapy for heart failure cost-effective compared to previous standard of care
Adding a sodium-glucose cotransporter-2 inhibitor to standard care had intermediate cost-effectiveness, but replacing an angiotensin-converting enzyme inhibitor with an angiotensin receptor-neprilysin inhibitor was only borderline cost-effective, a modeling study found.
https://immattersacp.org/weekly/archives/2023/06/13/1.htm
13 Jun 2023
Treat COPD symptoms, solve problems
Effectively managing chronic obstructive pulmonary disease means staying up to date on medications, devices, and delivery techniques.
https://immattersacp.org/archives/2024/04/treat-copd-symptoms-solve-problems.htm
1 Apr 2024
Cardiac societies issue new joint guideline on management of heart failure
The updated guideline recommends sodium-glucose cotransporter-2 inhibitors for many heart failure patients, regardless of their diabetes status, among other changes.
https://immattersacp.org/weekly/archives/2022/04/05/2.htm
5 Apr 2022
Collaboration with heart failure patients key
Comanaging cardiology patients after heart failure requires small adjustments, following recent guidelines, and patient involvement in decisions.
https://immattersacp.org/archives/2021/07/collaboration-with-heart-failure-patients-key.htm
1 Jul 2021
Frailer heart failure patients less likely to receive guideline-recommended therapy
A prospective analysis of patients with heart failure and reduced ejection fraction in Japan found that the proportion receiving angiotensin-converting enzyme inhibitors/angiotensin receptor blockers, beta-blockers, and mineralocorticoid receptor antagonists decreased as physical frailty increased.
https://immattersacp.org/weekly/archives/2023/06/20/4.htm
20 Jun 2023